Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2007
10/17/2007CN100342906C Use of polyproline polypeptide in preparing medicine for treating malignant tumour
10/16/2007US7282624 Making transgenic plants that harbour within their genome a chimeric gene which when expressed produces a cytotoxic protein, such as maize ribosome inactivating protein; sterility in plants
10/16/2007US7282622 Flower morphology of plants by targeting mads-box gene
10/16/2007US7282620 Animal does not develop anaphylaxis, a type I allergy, and specifically induces Arthus reaction, a type III allergy
10/16/2007US7282580 Protein molecule useful for inhibition of anthrax toxin
10/16/2007US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors
10/16/2007US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings
10/16/2007US7282576 Coactivators in the diagnosis and treatment of breast cancer
10/16/2007US7282572 Method and device for improving protein stability and solubility
10/16/2007US7282571 Concentrating a pyrene actin; mixing the concentrated pyrene actin with sucrose, a stabilizing agent, and a reducing agent, rapidly freezing
10/16/2007US7282567 Monoclonal antibody hPAM4
10/16/2007US7282566 PRO1779 polypeptide
10/16/2007US7282565 PRO362 polypeptides
10/16/2007US7282564 RNA interference pathway genes as tools for targeted genetic interference
10/16/2007US7282563 Opioid receptors and methods of use
10/16/2007US7282561 PRO16090 polypeptides
10/16/2007US7282560 PRO 4326 polypeptides
10/16/2007US7282559 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2007US7282558 PRO4329 polypeptide
10/16/2007US7282557 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
10/16/2007US7282556 Polynucleotides and polypeptides relating to the modulation of SIRPα-CD47
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282483 Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF
10/16/2007US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity
10/16/2007US7282477 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents
10/16/2007US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/16/2007US7282365 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen
10/16/2007US7282364 Expression cassette generated from these sequences; generating an immune response in a subject
10/16/2007US7282353 Protein isolation
10/16/2007US7282352 Substituting the endogenous signal peptide of a subunit of FSH with an amino acid sequence comprising the signal peptide of human growth hormone (hGH).
10/16/2007US7282351 Prostatic growth factor
10/16/2007US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening
10/16/2007US7282341 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time
10/16/2007US7282335 Anticancer, antitumor agents;monitoring mutant oncogens; detection cancer, tumor; signal amplification
10/16/2007US7282210 Process for the in vitro culture of different stages of tissular parasites
10/16/2007US7282209 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders
10/16/2007US7282208 Method for stimulating wound healing
10/16/2007US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
10/16/2007US7282204 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA
10/16/2007US7282201 Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin
10/16/2007US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders
10/16/2007US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
10/16/2007CA2326413C Process for enriching for helicobacter pylori neutrophil activating protein (nap)
10/16/2007CA2157375C Extraction of cell-bound protein from bordetella
10/16/2007CA2114250C Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases
10/16/2007CA2094243C Streptolysin o variants
10/14/2007CA2584894A1 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
10/13/2007CA2566832A1 Cyclised alpha-conotoxin peptides
10/11/2007WO2007115231A2 Cxcr4 modulators
10/11/2007WO2007115180A1 Fullerene assisted cell penetrating peptides
10/11/2007WO2007115064A2 Maize genes for controlling plant growth and organ size and their use in improving crop plants
10/11/2007WO2007114340A1 Pseudomonas aeruginosa outer membrane protein pa0427
10/11/2007WO2007114214A1 CRYSTAL OF PENICILLIN-BINDING PROTEIN (PBP) 2b
10/11/2007WO2007114139A1 Phage display by novel filamentous bacteriophage
10/11/2007WO2007113837A2 N-terminal vdac variants and uses thereof
10/11/2007WO2007113691A2 Peptide compound with biological activity, its preparation and its application
10/11/2007WO2007113488A1 Fibronectin type iii domain containing protein
10/11/2007WO2007113366A1 Use of compounds inducing the axonal development of neurones, therapeutic compositions containing them and applications thereof
10/11/2007WO2007113361A1 Treatment of disorders caused by changes in neurone axonal development
10/11/2007WO2007113205A1 Glp-1 peptide agonists
10/11/2007WO2007113001A2 Novel brachyspira pilosicoli genes and proteins and uses thereof
10/11/2007WO2007112953A1 Process for the purification of recombinant alpha 1-antitrypsin involving a step of anion exchange chromatography
10/11/2007WO2007112940A2 Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
10/11/2007WO2007112682A1 Recombinant human parathyroid hormone-related proteins and uses thereof
10/11/2007WO2007112677A1 Method of preparing human parathyroid hormone 1-34
10/11/2007WO2007112676A1 A human parathyroid hormone 1-34 fusion protein and expression vectors thereof
10/11/2007WO2007112633A1 Primers for in vitro diagnosing mutations within the autosomal recessive nonsyndromic hereditary hearing loss gene gjb2 and the use thereof
10/11/2007WO2007112566A1 Compositions and methods for treating atherosclerosis
10/11/2007WO2007097778A9 Novel restriction endonucleases, dna encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity
10/11/2007WO2007096859A3 Protection of the retina against laser injury by adnf peptides such as nap and sal
10/11/2007WO2007096201A3 Novel upases and uses thereof
10/11/2007WO2007087851A8 Method for producing epitomers and their uses on carrier microorganisms
10/11/2007WO2007085412B1 Fgf2-binding peptides and uses thereof
10/11/2007WO2007084364A3 Improved il-12 for expression in mammalian cells
10/11/2007WO2007074133A3 Compositions comprising an acylated insulin and zinc and method of making the said compositions
10/11/2007WO2007038264A3 Gapr-1 methods
10/11/2007WO2007010459A3 Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight against pathogenic fungi
10/11/2007WO2006124451A3 Anti-il-13 antibodies, compositions, methods and uses
10/11/2007WO2006109071A8 Vaccine against burkholderia infections
10/11/2007WO2006089660A3 Method for cleaning marine collagen and the treatment thereof to form porous sponges
10/11/2007WO2006044674A3 G-protein estrogen membrane receptor
10/11/2007WO2005115394A3 Prenyl-electrostatic switch, and methods of use
10/11/2007WO2004094617A3 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
10/11/2007WO2004056979A3 Recombinant virus production for the manufacturing of vaccines
10/11/2007WO2004053058A3 Junctional adhesion molecule splice variants
10/11/2007WO2004007527A3 Secreted proteins
10/11/2007US20070240243 Nucleic acid sequence for forming a transgenic plant with at least one of: tolerance to salt, cold weather, drought, low nitrogen conditions; crops
10/11/2007US20070240239 Axmi-003, a delta-endotoxin gene and methods for its use
10/11/2007US20070240237 Pesticidal Vip3 toxins toxin from Bacillus thuringiensis highly active against a wide range of lepidopteran insect pests is disclosed. The DNA encoding the pesticidal toxin; used to transform various prokaryotic and eukaryotic organisms to express the pesticidal toxin;crops; genetic engineering
10/11/2007US20070238890 transgenic oil palm comprising a recombined nucleic acid that is selectively expressed in the mesocarp, wherein the expression is regulated by an MT3-A regulatory nucleic acid; regulate gene expression in the mesocarp and/or senescent leaves of certain plants
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238861 Ribonucleases and methods of making them recombinantly
10/11/2007US20070238860 Mixing a protein solution with a refolding buffer at mixing conditions; obtaining a biologically active recombinant protein by reconstituting the protein from a denatured state to its active form
10/11/2007US20070238859 Wound healing agents; anticancer agents; cardiovascular disorders
10/11/2007US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238667 Compositions for treatment of cancer
10/11/2007US20070238666 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence
10/11/2007US20070238664 70 Human Secreted Proteins
10/11/2007US20070238662 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation